BTIG analyst Ryan Zimmerman upgraded Solventum (SOLV) to Buy from Neutral with a $100 price target The firm believes the company will find its “footing” in 2026. The company’s divestiture of its purification and filtration business helped reduce its debt, says BTIG, which cites Solventum’s execution against guidance and reduced buy-side expectations for the upgrade. It finds the stock’s setup “compelling” at current valuation levels.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum upgraded to Buy from Neutral at BTIG
- Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges
- Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential
- Solventum announces $1B share repurchase program
- Solventum to acquire Acera Surgical